1.
Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies.Eur Heart J. 2001;22(9):729-739.
2.
Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007;99(4):442-445. doi:10.1016/j.amjcard.2006.08.054
3.
Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002; 105(16):1909-1913. doi:10.1161/01.cir.0000014683.52177.b5
4.
Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004;109(9):1121-1126. doi:10.1161/01.CIR.0000 118496.44135.A7
5.
Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97(8):765-772. doi: 10.1161/01.cir.97.8.765
6.
Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21): 2550-2554. doi:10.1161/01.cir.103.21.2550
7.
Stevens PE, Levin A; kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-830. doi:10.7326/0003-4819-158-11-201306040-00007
8.
Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest. 2002;122(4):1322-1332. doi:10.1378/chest.122.4.1322
9.
Fajar JK, Heriansyah T, Rohman MS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J. 2018;70(Suppl 3):S406-S418. doi:10.1016/j.ihj.2018.01.032
10.
Refaat H, Tantawy A, Gamal AS, Radwan H. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Indian Heart J. 2021;73(1):35-43. doi:10.1016/j.ihj.2020.12.008
11.
Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96-102. doi:10.5847/wjem.j.issn.1920-8642.2014.02.003
12.
Mazhar J, Mashicharan M, Farshid A. Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction. Int J Cardiol Heart Vasc. 2015;10:8-12. doi:10.1016/j.ijcha.2015.11.002
13.
Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008;72(5):716-721. doi:10.1253/circj.72.716
14.
Cura FA, L’Allier PL, Kapadia SR, et al. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001;88(2):124-128. doi:10.1016/s0002-9149(01)01605-8
15.
Sabin P, Koshy AG, Gupta PN, et al. Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from medical college hospital, Trivandrum. Indian Heart J. 2017;69(Suppl 1):S34-S45. doi:10.1016/j.ihj.2016.12.012
16.
Ruiz-García J, Lerman A, Weisz G, et al. Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study. EuroIntervention. 2012;8(8):929-938. doi:10.4244/EIJV8I8A142
17.
Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24(2):471-476. doi:10.1016/0735-1097 (94)90305-0
18.
Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281-292. doi:10.1016/j.jacc.2009. 03.054
19.
Brilakis E. Chapter 20: Acute coronary syndromes−thrombus. In: Brilakis E, ed. Manual of percutaneous coronary interventions: a step-by-step approach. Elsevier. 2020;351-361.
20.
Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diab Vasc Dis Res. 2005;2(3):136-143. doi:10.3132/dvdr.2005.021
21.
Nair Rajesh G, Jayaprasad N, Madhavan S, et al. Predictors and prognosis of no-reflow during primary percutaneous coronary intervention. Proc (Bayl Univ Med Cent). 2018;32(1):30-33. doi:10.1080/08998280.2018.1509577